Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Social distancing

- PMLiVE

Biopharma industry encouraged by EMA’s COVID-19 transparency measures

IFPMA and EFPIA welcome new transparency measures for potential treatments and vaccines

- PMLiVE

Looking after the mental wellbeing of the Porterhouse family

At Porterhouse Medical Group, as a busy insight-led healthcare communications agency group, we recognise the importance of mental health and that mental health issues are a normal part of life...

Porterhouse Medical Group

OLED Medical Technology Saving Patient’s Sight During COVID-19 Pandemic

North East MedTech company secures investment agreement with Japanese tech giant

Onyx Health

- PMLiVE

Celltrion launches phase 3 trial of COVID-19 mAb

Investigational monoclonal antibody will be tested as a preventative treatment

- PMLiVE

Eli Lilly’s COVID-19 antibody trial paused due to safety issue

Company has voluntarily paused study amid safety review

- PMLiVE

Relief Therapeutics’ COVID-19 drug shows positive results ahead of trial readout

Patients treated in intensive care met survival threshold in open-label study

- PMLiVE

J&J halts COVID-19 vaccine study after unexplained participant illness

Company convened data and safety monitoring board to review event

- PMLiVE

Regeneron seeks US emergency use authorisation for COVID-19 antibody cocktail

If approved, the US government will make initial doses available at no cost

- PMLiVE

UK scientists begin testing BCG vaccine for severe COVID-19 protection

Researchers believe shot could help to protect against severe COVID-19

- PMLiVE

FDA publishes new guidelines for COVID-19 vaccine approval

New rules mean a COVID-19 shot is unlikely to be approved pre-election in the US

Accelerating Digital Health Innovation Success

Fard Johnmar, Founder of Enspektos, and Denise Pines, President of the Medical Board of California, discuss the concepts of “FemAging” and “ePatients”, and how COVID-19 has affected both of these. We explore an...

Impetus Digital

- PMLiVE

J&J signs deal with EU for 200 million COVID-19 vaccine doses

EU member states will have an option to secure 200 million additional doses

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links